Bota, D. A., Desjardins, A., Quinn, J. A., Rich, J. N., Vredenburgh, J. J., Sathornsumetee, S., … Reardon, D. A. (2007). Phase II trial of imatinib mesylate and hydroxyurea for adults with recurrent/progressive low-grade glioma. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 25). AMER SOC CLINICAL ONCOLOGY.

Bota, D. A., A. Desjardins, J. A. Quinn, J. N. Rich, J. J. Vredenburgh, S. Sathornsumetee, K. Goli, A. Salvado, H. S. Friedman, and D. A. Reardon. “Phase II trial of imatinib mesylate and hydroxyurea for adults with recurrent/progressive low-grade glioma.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 25. AMER SOC CLINICAL ONCOLOGY, 2007.

Bota DA, Desjardins A, Quinn JA, Rich JN, Vredenburgh JJ, Sathornsumetee S, et al. Phase II trial of imatinib mesylate and hydroxyurea for adults with recurrent/progressive low-grade glioma. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2007.

Bota, D. A., et al. “Phase II trial of imatinib mesylate and hydroxyurea for adults with recurrent/progressive low-grade glioma.” JOURNAL OF CLINICAL ONCOLOGY, vol. 25, no. 18, AMER SOC CLINICAL ONCOLOGY, 2007.

Bota DA, Desjardins A, Quinn JA, Rich JN, Vredenburgh JJ, Sathornsumetee S, Goli K, Salvado A, Friedman HS, Reardon DA. Phase II trial of imatinib mesylate and hydroxyurea for adults with recurrent/progressive low-grade glioma. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2007.